Pay in 4 interest-free payments of $30.59 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Immunogen: Recombinant fusion protein of human MED18(NP_001120822
A quantitative method for Rituximab has been developed and optimized for pharmacokinetic assessment of samples
Lane 1: HepG2 whole cell lysate(10ug)
Swiss-Prot: Q9UGL1(Human) Q80Y84(Mouse)
Immunogen: A synthesized peptide derived from human DDIT3 around the phosphorylation site of Ser30
EEA1 Polyclonal Antibody-BS74280 Cells in 3D Hydrogels Immunogen: Recombinant fusion protein ofEEA1 Polyclonal Antibody Sizes: 50l, 100l Catalogue Numbers: BS74280 50, BS74280 100 Product: 1mg ml in PBS with 0. 02% sodium azide, 50% glycerol, pH7. 2 Swiss Prot: Q15075 Host: Rabbit Reactivity: Human, Mouse, Rat Applications: WB, IHC All Applications: WB,1: 500 1: 2000 IHC,1: 50 1: 200 Background: Binds phospholipid vesicles containing phosphatidylinositol 3 phosphate and participates in endosomal trafficking. Purification and Purity: The